Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

TIP60 is required for tumorigenesis in non-small cell lung cancer.

Shibahara, Daisuke; Akanuma, Naoki; Kobayashi, Ikei S; Heo, Eunyoung; Ando, Mariko; Fujii, Masanori; Jiang, Feng; Prin, P Nicholas; Pan, Gilbert; Wong, Kwok-Kin; Costa, Daniel B; Bararia, Deepak; Tenen, Daniel G; Watanabe, Hideo; Kobayashi, Susumu S.

Cancer Sci ; 114(6): 2400-2413, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-36916958

2.

Clinical Benefit of Tyrosine Kinase Inhibitors in Advanced Lung Cancer with EGFR-G719A and Other Uncommon EGFR Mutations.

Sehgal, Kartik; Rangachari, Deepa; VanderLaan, Paul A; Kobayashi, Susumu S; Costa, Daniel B.

Oncologist ; 26(4): 281-287, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-32969527

3.

Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer.

Viray, Hollis; Rangachari, Deepa; Costa, Daniel B.

N Engl J Med ; 386(18): 1769-1770, 2022 05 05.

Artículo en Inglés | MEDLINE | ID: mdl-35507494

4.

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.

Chen, Zhao; Cheng, Katherine; Walton, Zandra; Wang, Yuchuan; Ebi, Hiromichi; Shimamura, Takeshi; Liu, Yan; Tupper, Tanya; Ouyang, Jing; Li, Jie; Gao, Peng; Woo, Michele S; Xu, Chunxiao; Yanagita, Masahiko; Altabef, Abigail; Wang, Shumei; Lee, Charles; Nakada, Yuji; Peña, Christopher G; Sun, Yanping; Franchetti, Yoko; Yao, Catherine; Saur, Amy; Cameron, Michael D; Nishino, Mizuki; Hayes, D Neil; Wilkerson, Matthew D; Roberts, Patrick J; Lee, Carrie B; Bardeesy, Nabeel; Butaney, Mohit; Chirieac, Lucian R; Costa, Daniel B; Jackman, David; Sharpless, Norman E; Castrillon, Diego H; Demetri, George D; Jänne, Pasi A; Pandolfi, Pier Paolo; Cantley, Lewis C; Kung, Andrew L; Engelman, Jeffrey A; Wong, Kwok-Kin.

Nature ; 483(7391): 613-7, 2012 Mar 18.

Artículo en Inglés | MEDLINE | ID: mdl-22425996

5.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Shaw, Alice T; Ou, Sai-Hong I; Bang, Yung-Jue; Camidge, D Ross; Solomon, Benjamin J; Salgia, Ravi; Riely, Gregory J; Varella-Garcia, Marileila; Shapiro, Geoffrey I; Costa, Daniel B; Doebele, Robert C; Le, Long Phi; Zheng, Zongli; Tan, Weiwei; Stephenson, Patricia; Shreeve, S Martin; Tye, Lesley M; Christensen, James G; Wilner, Keith D; Clark, Jeffrey W; Iafrate, A John.

N Engl J Med ; 371(21): 1963-71, 2014 Nov 20.

Artículo en Inglés | MEDLINE | ID: mdl-25264305

6.

Lung Cancer with a High Tumor Mutational Burden.

VanderLaan, Paul A; Rangachari, Deepa; Costa, Daniel B.

N Engl J Med ; 379(11): 1093, 2018 09 13.

Artículo en Inglés | MEDLINE | ID: mdl-30211492

7.

Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.

Steidl, Ulrich; Rosenbauer, Frank; Verhaak, Roel G W; Gu, Xuesong; Ebralidze, Alexander; Otu, Hasan H; Klippel, Steffen; Steidl, Christian; Bruns, Ingmar; Costa, Daniel B; Wagner, Katharina; Aivado, Manuel; Kobbe, Guido; Valk, Peter J M; Passegué, Emmanuelle; Libermann, Towia A; Delwel, Ruud; Tenen, Daniel G.

Nat Genet ; 38(11): 1269-77, 2006 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-17041602

8.

The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors.

Kobayashi, Ikei S; Shaffer, William; Viray, Hollis; Rangachari, Deepa; VanderLaan, Paul A; Kobayashi, Susumu S; Costa, Daniel B.

JTO Clin Res Rep ; 5(1): 100614, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-38229766

9.

A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice.

Viray, Hollis; Piper-Vallillo, Andrew J; Widick, Page; Academia, Emmeline; Shea, Meghan; Rangachari, Deepa; VanderLaan, Paul A; Kobayashi, Susumu S; Costa, Daniel B.

Cancers (Basel) ; 16(6)2024 Mar 07.

Artículo en Inglés | MEDLINE | ID: mdl-38539415

10.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Kwak, Eunice L; Bang, Yung-Jue; Camidge, D Ross; Shaw, Alice T; Solomon, Benjamin; Maki, Robert G; Ou, Sai-Hong I; Dezube, Bruce J; Jänne, Pasi A; Costa, Daniel B; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A; Sequist, Lecia V; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C; Shreeve, S Martin; Ratain, Mark J; Settleman, Jeffrey; Christensen, James G; Haber, Daniel A; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I; Clark, Jeffrey W; Iafrate, A John.

N Engl J Med ; 363(18): 1693-703, 2010 Oct 28.

Artículo en Inglés | MEDLINE | ID: mdl-20979469

11.

Ascending role of next-generation ALK inhibitors.

Costa, Daniel B.

Lancet Oncol ; 18(7): 837-839, 2017 07.

Artículo en Inglés | MEDLINE | ID: mdl-28602777

12.

EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications.

Yasuda, Hiroyuki; Kobayashi, Susumu; Costa, Daniel B.

Lancet Oncol ; 13(1): e23-31, 2012 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-21764376

13.

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

Camidge, D Ross; Bang, Yung-Jue; Kwak, Eunice L; Iafrate, A John; Varella-Garcia, Marileila; Fox, Stephen B; Riely, Gregory J; Solomon, Benjamin; Ou, Sai-Hong I; Kim, Dong-Wan; Salgia, Ravi; Fidias, Panagiotis; Engelman, Jeffrey A; Gandhi, Leena; Jänne, Pasi A; Costa, Daniel B; Shapiro, Geoffrey I; Lorusso, Patricia; Ruffner, Katherine; Stephenson, Patricia; Tang, Yiyun; Wilner, Keith; Clark, Jeffrey W; Shaw, Alice T.

Lancet Oncol ; 13(10): 1011-9, 2012 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-22954507

14.

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.

Le, Xiuning; Nadler, Eric; Costa, Daniel B; Heymach, John Victor.

Target Oncol ; 18(6): 807-817, 2023 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-37792237

15.

ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor-Responsive Lung Cancer Driver Oncogene.

Schoepflin, Zachary R; Academia, Emmeline; Osataphan, Soravis A; Rangachari, Deepa; Sharifi, Sheida; VanderLaan, Paul A; Costa, Daniel B.

JTO Clin Res Rep ; 4(4): 100489, 2023 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-36994308

16.

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors.

Shaffer, William; Kobayashi, Ikei S; Sentana-Lledo, Daniel; Sundararaman, Shriram; Lee, Meghan D; Rangachari, Deepa; VanderLaan, Paul A; Kobayashi, Susumu S; Costa, Daniel B.

Lung Cancer ; 181: 107250, 2023 07.

Artículo en Inglés | MEDLINE | ID: mdl-37196448

17.

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates.

Sentana-Lledo, Daniel; Academia, Emmeline; Viray, Hollis; Rangachari, Deepa; Kobayashi, Susumu S; VanderLaan, Paul A; Costa, Daniel B.

Transl Lung Cancer Res ; 12(7): 1590-1610, 2023 Jul 31.

Artículo en Inglés | MEDLINE | ID: mdl-37577308

18.

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).

Burns, Laura; Hsu, Chih-Yuan; Whisenant, Jennifer G; Marmarelis, Melina E; Presley, Carolyn J; Reckamp, Karen L; Khan, Hina; Jo Fidler, Mary; Bestvina, Christine M; Brahmer, Julie; Puri, Sonam; Patel, Jyoti D; Halmos, Balazs; Hirsch, Fred R; Liu, Stephen V; Costa, Daniel B; Goldberg, Sarah B; Feldman, Lawrence E; Mamdani, Hirva; Puc, Matthew; Mansfield, Aaron S; Islam, Nahida; Scilla, Katherine A; Garassino, Marina C; Horn, Leora; Peters, Solange; Wakelee, Heather A; Charlot, Marjory; Tapan, Umit.

Lung Cancer ; 186: 107423, 2023 12.

Artículo en Inglés | MEDLINE | ID: mdl-37995456

19.

Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells.

Will, Britta; Siddiqi, Tanya; Jordà, Meritxell Alberich; Shimamura, Takeshi; Luptakova, Katarina; Staber, Philipp B; Costa, Daniel B; Steidl, Ulrich; Tenen, Daniel G; Kobayashi, Susumu.

Blood ; 115(14): 2901-9, 2010 Apr 08.

Artículo en Inglés | MEDLINE | ID: mdl-20160166

20.

ALK inhibitors: plateauing systemic and intracranial activity?